6533b832fe1ef96bd129ad6b

RESEARCH PRODUCT

Myopathy with hexagonally cross-linked crystalloid inclusions: delineation of a clinico-pathological entity.

Michel FardeauPascal LaforêtHans H. GoebelThomas VoitFederico García-bragadoMonique PiraudG StoltenburgJuan-jose PozaChristophe E. DepuydtJean PougetCarsten G. BönnemannGuy BrochierJoachim WeisBruno EymardKristl G. ClaeysAndoni UrtizbereaWolfgang KleinerJean-françois PellissierDominique Figarella-brangerNorma B. RomeroPatrick J. WillemsAna-maria Cobo

subject

myalgiaAdultMaleWeaknessPathologymedicine.medical_specialtyAdolescentCaveolin 3Blotting WesternExercise intoleranceNemaline myopathyMuscular DiseasesTrichromemedicineHumansAge of OnsetMyopathyMuscle SkeletalCreatine KinaseExerciseGenetics (clinical)Muscle Weaknessbusiness.industryMuscle weaknessMiddle Agedmedicine.diseaseImmunohistochemistryPhenotypeNeurologyPediatrics Perinatology and Child HealthFemaleNeurology (clinical)medicine.symptombusinessRhabdomyolysis

description

A novel myopathy characterized by hexagonally cross-linked tubular arrays has been reported in five patients. We studied the clinical and histopathological features of five additional unrelated patients with this myopathy. Patients experienced exercise intolerance with exercise-induced myalgia and weakness, without rhabdomyolysis. One patient additionally presented mild permanent pelvic girdle muscle weakness. Age at onset varied between 13 and 56 years. The inclusions were eosinophilic on H and E, bright red with modified Gomori’s trichrome stains, present in type 2 fibers, and revealed immunoreactivity selectively for a caveolin-3-antibody. Ultrastructurally, the inclusions showed a highly organized, hexagonally cross-linked crystalloid structure. Mutations in the caveolin-3 encoding gene were excluded. Biochemical assessment of glycogenolysis in muscle was normal. Inherited or sporadic myopathy with hexagonally cross-linked tubular arrays is associated with a homogeneous clinical and histopathological phenotype. This myopathy should be included in the differential diagnosis of patients with exercise intolerance and myalgia.

10.1016/j.nmd.2010.06.006https://pubmed.ncbi.nlm.nih.gov/20637616